Pharming Group N.V. (PHAR) Non-Current Debt (2019 - 2021)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Pharming (PHAR) has disclosed Non-Current Debt for 3 consecutive years, with $165000.0 as the latest value for Q4 2021.

• For the quarter ending Q4 2021, Non-Current Debt fell 20.01% year-over-year to $165000.0, compared with a TTM value of $165000.0 through Dec 2021, down 20.01%, and an annual FY2021 reading of $165000.0, down 22.17% over the prior year.
• Non-Current Debt was $165000.0 for Q4 2021 at Pharming, down from $206266.1 in the prior quarter.
• Across five years, Non-Current Debt topped out at $19.1 million in Q4 2019 and bottomed at $165000.0 in Q4 2021.
• Average Non-Current Debt over 3 years is $6.5 million, with a median of $206266.1 recorded in 2020.
• The sharpest move saw Non-Current Debt plummeted 98.92% in 2020, then fell 20.01% in 2021.
• Year by year, Non-Current Debt stood at $19.1 million in 2019, then tumbled by 98.92% to $206266.1 in 2020, then decreased by 20.01% to $165000.0 in 2021.
• Business Quant data shows Non-Current Debt for PHAR at $165000.0 in Q4 2021, $206266.1 in Q4 2020, and $19.1 million in Q4 2019.

Peer Comparison